Mentions
Extended reach
Total likes
Video views
AI synopsis
The posts express support for the idea that combining Bifidobacterium longum subsp. infantis with HMOs can significantly boost health benefits, with examples focused on the synergistic effects and relevance to industry practices. The tone, referencing research and corporate involvement, emphasizes an optimistic view of the potential advancements in infant gut health, but the overall engagement and interest suggest a cautious optimism rather than full enthusiasm.
Most discussions acknowledge the significance of the research findings, aligning with the idea that combining probiotics and prebiotics enhances gut health benefits.
Participants demonstrate some curiosity about the practical applications, especially with references to research and companies involved, but overall interest remains moderate.
Responders refer to specific aspects of the study, such as the synergistic effects and implications for infant health, showing a level of thoughtful engagement, though not deeply analytical.
The discussions reflect a shared belief that these findings could influence future probiotic formulations or infant nutrition strategies, indicating perceived moderate impact.
Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fatty acid production ex vivo @Nestle R&D https://t.co/I2fNd4XixB
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
This scientific overview discusses the development of Infipiro A2, a specialized infant formula enriched with 6HMO and lactic Kuo. It highlights its design to support infant health, immune functions, and gut health…
This video introduces the scientific development of Nestlé's NAN INFINIPRO A2, highlighting its innovative blend of 6HMO and prebiotics to support infant digestion and immunity, aiming to optimize early childhood health…
This video explores how human milk oligosaccharide concentrations vary during different lactation stages and among populations, influenced by maternal genetics, gestational age, and ethnicity, based on a comprehensive…
The review analyzes how the concentrations of human milk oligosaccharides vary throughout lactation and across populations, highlighting significant changes from colostrum to late milk stages and factors influencing HMO…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
RT @BoehmeMarcus: Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fa…
Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fatty acid production ex vivo @Nestle R&D https://doi.org/10.1038/s42003-024-06628-1
Combining Bifidobacterium longum subsp. infantis and human milk oligosaccharides synergistically increases short chain fatty acid production ex vivo @Nestle R&D https://t.co/I2fNd4XixB